Home > Drug Search >
  • company_query: Bayhill Therapeutics
  •   > 
Drug Filter
Category:
chemistry (12) biology (17)
Status:
Approved (2) BLA Filing (1) Phase Ⅲ (5) Phase Ⅱ (16) Phase Ⅰ (5)
Clinical Stage:
Pending (3) Active (17) Discontinued (7)
Bio-Type:
Gene therapy (2) Cell therapy (1) Vaccine (7) Recombinant cytokines (1) Fusion protein (1)
Indication:
Alzheimer's disease (AD) (1) Anemia (2) Asthma (2) Chronic obstructive pulmonary disease (COPD) (1) ischaemic heart disorder (1) Crohn's disease (1) Cystic fibrosis (CF) (1) Duchenne muscular dystrophy (DMD) (2) Eczema (1) Hepatocellular carcinoma (HCC) (1) HIV infection (4) Major depressive disorder (MDD) (1) Renal osteodystrophy (1) Multiple myeloma (MM) (1) Multiple sclerosis (MS) (2) Myelodysplastic syndrome (MDS) (1) Vascular disorders (1) Osteoarthritis (OA) (1) Lung disorders (1) Peripheral arterial disease (PAD) (1) Renal cell carcinoma (1) Solid tumours (4) Head and neck cancer (1) Vulvar intraepithelial neoplasia (1) Anal intraepithelial neoplasia (1) neurodermatitis (1) Diabetic angiopathies (1) Skin pruritus (1) Cervical carcinoma (1) Sickle cell disease (1) Hematological cancer (1) Gastroparesis diabeticorum (1) Glioblastoma (1) Mesothelioma (1) Gastroparesis (1) Bacterial infection (1) Diabetic neuropathy (1) Thelassemia (2) Vascular calcification (1) Inflammation (1)
Country:
Aprv. Year:
1995 (1) 2017 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top